Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co

Drug Profile

Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co

Alternative Names: Aethoxysklerol; Asclera

Latest Information Update: 16 Jul 2010

Price : $50

At a glance

  • Originator Chemische Fabrik Kreussler & Co
  • Class Polyethylene glycols; Sclerosants; Vascular disorder therapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Varicose veins

Most Recent Events

  • 15 Jul 2010 Launched for Varicose veins in USA (IV)
  • 30 Mar 2010 US FDA approves polidocanol injection for the treatment of varicose veins
  • 19 Feb 2010 BioForm Medical has been acquired by Merz Pharma; they are now operating as a wholly-owned subsidiary under the name Merz Aesthetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top